Education
About Us
Working with TipRanks
Follow Us
Ferrara Napoleone Insider Profile
4 Followers
Ferrara Napoleone, Director at TuHURA Biosciences, holds ― shares in TuHURA Biosciences (Ticker: HURA), holds 504.00K shares in Kalaris Therapeutics (Ticker: KLRS). Most recently, Ferrara Napoleone ― shares of TuHURA Biosciences on ― for an estimated value of ―.
Ferrara Napoleone has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ferrara Napoleone holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ferrara Napoleone
Ferrara Napoleone's Trading History
TuHURA Biosciences
―
Director
―
―
Kalaris Therapeutics
Mar 18, 2025
Director
Uninformative Buy
―
$1.24M
List of latest transactions for each holding click on a transaction to see Ferrara Napoleone's performance on stock
You May Also Like
Ferrara Napoleone insider profile FAQ
What is the percentage of profitable transactions made by Ferrara Napoleone?
The percentage of profitable transactions made by Ferrara Napoleone is ―.
What is the average return per transaction made by Ferrara Napoleone?
The average return per transaction made by Ferrara Napoleone is ―.
What stocks does Ferrara Napoleone hold?
Ferrara Napoleone holds: HURA, KLRS stocks.
What was Ferrara Napoleone’s latest transaction?
Ferrara Napoleone latest transaction was an Uninformative Buy of ―.
What was Ferrara Napoleone's most profitable transaction?
Ferrara Napoleone’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ferrara Napoleone's role in TuHURA Biosciences?
Ferrara Napoleone's role in TuHURA Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.